These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 15066926)
1. Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study. Lacey JV; Potischman N; Madigan MP; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Lurain JR; Fillmore CM; Sherman ME; Brinton LA Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):607-12. PubMed ID: 15066926 [TBL] [Abstract][Full Text] [Related]
2. Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk. Oh JC; Wu W; Tortolero-Luna G; Broaddus R; Gershenson DM; Burke TW; Schmandt R; Lu KH Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):748-52. PubMed ID: 15159305 [TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Krajcik RA; Borofsky ND; Massardo S; Orentreich N Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045 [TBL] [Abstract][Full Text] [Related]
4. Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women. Grønbaek H; Flyvbjerg A; Mellemkjaer L; Tjønneland A; Christensen J; Sørensen HT; Overvad K Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1759-64. PubMed ID: 15533904 [TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factors and breast cancer risk in Chinese women. Yu H; Jin F; Shu XO; Li BD; Dai Q; Cheng JR; Berkel HJ; Zheng W Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):705-12. PubMed ID: 12163322 [TBL] [Abstract][Full Text] [Related]
6. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands. Vrieling A; Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Keinan-Boker L; van Gils CH; Peeters PH Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992 [TBL] [Abstract][Full Text] [Related]
7. Serum levels of insulin-like growth factor-I and -II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer. Serrano ML; Romero A; Cendales R; Sánchez-Gómez M; Bravo MM Biomedica; 2006 Jun; 26(2):258-68. PubMed ID: 16925098 [TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China. Chokkalingam AP; McGlynn KA; Gao YT; Pollak M; Deng J; Sesterhenn IA; Mostofi FK; Fraumeni JF; Hsing AW Cancer Res; 2001 Jun; 61(11):4333-6. PubMed ID: 11389055 [TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II. Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584 [TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factors and prostate cancer: a population-based case-control study in China. Chokkalingam AP; Pollak M; Fillmore CM; Gao YT; Stanczyk FZ; Deng J; Sesterhenn IA; Mostofi FK; Fears TR; Madigan MP; Ziegler RG; Fraumeni JF; Hsing AW Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850 [TBL] [Abstract][Full Text] [Related]
11. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk. Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358 [TBL] [Abstract][Full Text] [Related]
12. Association between components of the insulin-like growth factor system and endometrial cancer risk. Augustin LS; Dal Maso L; Franceschi S; Talamini R; Kendall CW; Jenkins DJ; Vidgen E; La Vecchia C Oncology; 2004; 67(1):54-9. PubMed ID: 15459496 [TBL] [Abstract][Full Text] [Related]
13. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer. Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768 [TBL] [Abstract][Full Text] [Related]
14. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study. Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911 [TBL] [Abstract][Full Text] [Related]
15. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study. Kahán Z; Gardi J; Nyári T; Földesi I; Hajnal-Papp R; Ormándi K; Lázár G; Thurzó L; Schally AV Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200 [TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor (IGF)-1, IGF-binding protein-3, and pancreatic cancer in male smokers. Stolzenberg-Solomon RZ; Limburg P; Pollak M; Taylor PR; Virtamo J; Albanes D Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):438-44. PubMed ID: 15006921 [TBL] [Abstract][Full Text] [Related]
17. Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway. Vatten LJ; Holly JM; Gunnell D; Tretli S Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2097-100. PubMed ID: 18708402 [TBL] [Abstract][Full Text] [Related]
18. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial. Fairey AS; Courneya KS; Field CJ; Bell GJ; Jones LW; Mackey JR Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):721-7. PubMed ID: 12917202 [TBL] [Abstract][Full Text] [Related]
19. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer. Johansson H; Baglietto L; Guerrieri-Gonzaga A; Bonanni B; Mariette F; Macis D; Serrano D; Sandri MT; Decensi A Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047 [TBL] [Abstract][Full Text] [Related]
20. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort. Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]